WASHINGTON, May 11 -- Food and Drug Administration has issued a notice called: Pulmonary Tuberculosis: Developing Drugs for Treatment; Guidance for Industry; Availability.
The notice was published in the Federal Register on May 11 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry titled "Pulmonary Tuberculosis: Developing Drugs for Treatment." The purpose of this guidance is to assist sponsors in the clinical development of new antibacterial drugs for the treatment of pulmonary tuberculosis (TB). This guidance finalizes the draft guidance of the same title issued on December 15...